← SynDRA
VGX-1027
SynDRA canonical compound SYN0024982 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | TLR4 |
|---|
| Mechanism of action | Tumor necrosis factor receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Tumor necrosis factor receptor antagonist
Cross-references
Synonyms
- VGX 1027
- Zenuzolac
- Gls-1027
- GIT-27
- GIT-027
- GLS1027
- VGX1027
- git-27
- 2-(3-phenyl-4,5-dihydroisoxazol-5-yl)acetic acid
- 4,5-DIHYDRO-3-PHENYL-5-ISOXAZOLEACETIC ACID
- 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic Acid
- GIT27
- SCHEMBL1404343
- CHEMBL1320667
- CTK5C2027
- VGX-127
- EX-A366
- DTXSID50445023
- AOB1858
- MUFJHYRCIHHATF-UHFFFAOYSA-N
- MolPort-022-917-316
- HMS3653J11
- BCP09284
- VGX-1027(GIT 27)
- MFCD08696167
- s7515
- 2792AH
- GIT-27 (VGX-1027)
- AKOS022538967
- AKOS000282755
- CS-2737
- NCGC00186000-02
- NCGC00186000-01
- AK175225
- HY-15507
- AB0279943
- KB-272590
- Gls 1027
- AKT814N13R
Look up VGX-1027 in the interactive SynDRA portal →